Successful Conservative Management of a Traumatic Intramural Duodenal Hematoma Using a Double Elementary Diet Tube.

Intern MedFeb 1, 2026 (epub)
Case ReportGastroenterology

Jun-Ichi Hanatani, Norihisa Nishimura, Natsumi Shibasaki et al.

✦ AI-curated · Sources linked

Case in brief

A 49-year-old man presented with anorexia and vomiting after abdominal trauma. Computed tomography showed duodenal obstruction, and non-contrast MRI demonstrated a subacute intramural hematoma; together with the trauma history, these findings supported traumatic intramural duodenal hematoma. An endoscopically placed double elementary diet (W-ED) tube provided gastric decompression and enteral nutrition. He was managed without surgery or central venous nutrition, resumed oral intake after 1 month, and had complete resolution confirmed at 3 months.

What made this case unusual

The W-ED tube was used to provide both gastric decompression and enteral nutrition during conservative management, avoiding surgery and central venous nutrition.

Diagnostic / clinical pearl

In a patient with duodenal obstruction after abdominal trauma, MRI may help identify an intramural hematoma when CT shows the obstruction.

Source

PubMed · PMID 41621875

Published in Intern Med. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Gastroenterology

Clinical ResearchOncology (Medical)

Zamtocabtagene autoleucel, a tandem CD20-CD19-directed CAR T-cell therapy, for second line treatment of large B-cell lymphoma in patients ineligible for transplantation (DALY 2-EU): primary analysis of an open-label, multicentre, randomised phase 2 study.

DALY 2-EU was an open-label, multicentre, randomised phase 2 trial comparing tandem CD20-CD19-directed zamtocabtagene autoleucel (zamto-cel) with R-GemOx in adults with second-line relapsed or refractory large B-cell…

Lancet OncolOct 27, 2026Read summary
Clinical ResearchOncology (Medical)

Neoadjuvant short-course radiotherapy followed by camrelizumab and chemotherapy versus standard of care for locally advanced rectal cancer (UNION): a prespecified interim analysis of a multicentre, open-label, randomised, phase 3 trial.

UNION was a multicentre, open-label, randomised phase 3 trial at nine hospitals in China comparing neoadjuvant short-course radiotherapy followed by camrelizumab plus CAPOX with long-course chemoradiotherapy followed by…

Lancet OncolOct 25, 2026Read summary
Clinical ResearchHematology

Efficacy and safety of mitapivat in patients with sickle cell disease (RISE UP): a phase 3, double-blind, global, randomised, placebo-controlled trial.

RISE UP was a phase 3, double-blind, global, randomised, placebo-controlled trial conducted at 69 sites in 15 countries. It evaluated twice-daily mitapivat in patients older than 16 years with sickle cell disease…

LancetOct 24, 2026Read summary

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text
Create my personalized digestSee plans

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.